Scinai Immunotherapeutics (SCNI) Exchange Rate Effect (2018 - 2024)
Scinai Immunotherapeutics' (SCNI) quarterly Exchange Rate Effect came in at $2000.0 in Q4 2024, up 114.29% year-over-year from $933.33 in Q1 2024, and up 101.52% quarter-over-quarter from -$132000.0 in Q3 2024.
Powered by 
Analysis
Scinai Immunotherapeutics (SCNI) Exchange Rate Effect (2018 - 2024) Analysis & Trends
Scinai Immunotherapeutics has disclosed Exchange Rate Effect across 7 years of filings, most recently posting $2000.0 for Q4 2024.
- In Q4 2024, Exchange Rate Effect rose 114.29% year-over-year to $2000.0; the TTM figure through Dec 2024 stood at -$137000.0 (up 49.63% YoY), while the FY2025 annual figure was $1000.0, up 111.11% from the prior year.
- Exchange Rate Effect came in at $2000.0 for Q4 2024 at Scinai Immunotherapeutics, up from -$132000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $2.0 million in Q3 2021 to a low of -$987000.0 in Q3 2022.
- Average Exchange Rate Effect over 5 years is -$57352.9, with a median of -$151000.0 recorded in 2022.
- Year-over-year, Exchange Rate Effect jumped 1210.67% in 2021 and sank 1985.71% in 2024.
- Over 5 years, Exchange Rate Effect stood at $544000.0 in 2020, then sank by 153.86% to -$293000.0 in 2021, then jumped by 48.46% to -$151000.0 in 2022, then soared by 90.73% to -$14000.0 in 2023, then soared by 114.29% to $2000.0 in 2024.
- Per Business Quant data, the three most recent Exchange Rate Effect figures were $2000.0 in Q4 2024, -$132000.0 in Q3 2024, and -$14000.0 in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 315,000.00 |
| 10 | Scinai Immunotherapeutics | 1.52 Bn | 1.52 Bn | -1.25 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | -132,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Jun 30, 2023 | -41,000.00 |
| Mar 31, 2023 | -224,000.00 |
| Dec 31, 2022 | -151,000.00 |
| Sep 30, 2022 | -987,000.00 |
| Jun 30, 2022 | -480,000.00 |
| Mar 31, 2022 | -359,000.00 |
| Dec 31, 2021 | -293,000.00 |
| Sep 30, 2021 | 1.98 Mn |
| Jun 30, 2021 | -360,000.00 |
| Mar 31, 2021 | 356,000.00 |
| Dec 31, 2020 | 544,000.00 |
| Sep 30, 2020 | -178,000.00 |
| Jun 30, 2020 | -642,000.00 |
| Dec 31, 2019 | -1.90 Mn |
| Sep 30, 2019 | -1.66 Mn |
| Mar 31, 2019 | -496,000.00 |